CARB certifies all UV lighting product families from Healthcare Lighting®

ATLANTA, November 17, 2021 – Acuity Brands, Inc. (NYSE: AYI) announced that the California Air Resources Board (CARB) has certified that all UV lighting product families from Healthcare Lighting® available today have been tested and found to comply with the State of California’s electrical safety and ozone requirements for Indoor Air Cleaning Devices. The product families consist of HDM™ fixtures with Care222® technology, EvolAIR UV™ luminaires powered by UV Angel Clean Air™ Technology, and PulseX™ devices with Violet Defense® Technology. In addition, these three product families are registered, or are currently waiting on registration, in the eight U.S. states that currently require state EPA registration.

“Our Healthcare Lighting UV product portfolio offers a diverse set of disinfection* technology solutions to meet our customers’ varied requirements for reducing active pathogens¹ on surfaces and/or in the air, including strategies for occupied and unoccupied spaces,” said Cleveland Blankenship, Business Unit Leader, Healthcare Lighting. “We are very pleased that all of our UV lighting products are now CARB-certified to confirm that they meet California’s stringent emission standards. All such certified devices produce an ozone emission concentration of less than 0.050 parts per million.”

The Healthcare UV lighting product portfolio consists of:

HDM luminaires with Care222 technology which feature a filtered far-UVC module with patent-pending dosing electronics: The Care222 module is the first far-UVC filtered 222nm solution to be UL listed for use in occupied spaces. Results from laboratory testing and clinical studies suggest that the filtered UV light emitted from the Care222 lamp can inactivate known viruses and other pathogens¹, including SARS-CoV-2², on surfaces and in air. When used within appropriate parameters, the 222nm wavelength emitted from the Care222 lamp inactivates viruses and bacteria at energy levels that do not penetrate living tissue in skin or beyond the tear layer in eyes, allowing spaces in which the lamps are used to remain occupied during use.

EvoAIR UV fixtures powered by UV Angel Clean Air™ Technology which use controlled air to reduce pathogenic bioburden¹ in occupied spaces: This automated continuous UVC air treatment system continuously circulates pathogen-contaminated air through a sealed and filtered chamber and treats it with high-intensity 254nm UV-C light to inactivate bacteria, fungus, and viruses before returning air to the space.

PulseX devices with Violet Defense Technology which feature a patented pulsed xenon lamp and lens configuration to deliver broad-spectrum UV light, leading to a quick reduction of pathogenic bioburden¹: Available in drop-in ceiling, recessed hard ceiling, or surface ceiling/wall mount options. An integrated occupancy sensor and optional nLight® wired controls safeguard against a treatment cycle occurring when spaces are occupied.

To verify the Healthcare Lighting UV lighting products that are on the California’s certified Indoor Cleaning Devices list, please visit: List of CARB-Certified Air Cleaning Devices | California Air Resources Board: https://ww2.arb.ca.gov/list-carb-certified-air-cleaning-devices. For more information about Healthcare Lighting products, visit https://www.acuitybrands.com/who-we-are/acuity-brands-lighting/healthcare-lighting.

¹Refer to product specification sheets at acuitybrands.com/UV-Products for efficacy claims and claim substantiation regarding specific products and pathogens - https://www.acuitybrands.com/-/media/abl/acuitybrands/files/resources/uv-light-disinfection-technology/uv-published-research-guide.pdf?forceBehavior=open

² In a 2020 study, Hiroshima University confirmed that under laboratory conditions, a dose of 3 mJ/cm2 of 222nmUVC irradiation, with an exposure time of 30 seconds inactivated 99.7% of SARS-CoV-2 on a surface. Ushio’s Care222 UV-C disinfection module was placed 24 cm above the surface of the plates in which the viral samples were placed. To read study: Effectiveness of 222-nm ultraviolet light on disinfecting SARS-CoV-2 surface contamination at https://www.ajicjournal.org/article/S0196-6553(20)30809-9/fulltext

*All references to “disinfection” are referring generally to bioburden reduction and are not intended to refer to any specific definition of the term as may be used for other purposes by the U.S. Food and Drug Administration or the U.S. Environmental Protection Agency. Bioburden reduction is a function of fixture run time, distance to the UV light source, airflow, room size and/or other factors, and the level of reduction will vary within a specific space. Neither the disinfection technology as incorporated in Acuity Brands products nor the products themselves are intended for use as a medical device or for the disinfection of medical devices.

All trademarks referenced are the property of their respective owners.

About Acuity Brands

Acuity Brands, Inc. (NYSE: AYI) is a market-leading industrial technology company. Through its two business segments, Acuity Brands Lighting and Lighting Controls (ABL) and the Intelligent Spaces Group (ISG), the Company designs, manufactures, and brings to market products and services that make the world more brilliant, productive, and connected. Acuity Brands achieves growth through the development of innovative new products and services, including building management systems, lighting, lighting controls, and location-aware applications.

Acuity Brands is based in Atlanta, Georgia, with operations across North America, Europe, and Asia. The Company is powered by approximately 13,000 dedicated and talented associates. Visit us at www.acuitybrands.com